Computational techniques for lead discovery from nature

Current Pharmaceutical Design

Volumn 16, Issue 15, 2010, Pages 1654-1655

  Rollinger, Judith M ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; GLYCOPROTEIN P; MOLECULAR SCAFFOLD; NATURAL PRODUCT; NEW DRUG; BIOLOGICAL PRODUCT;

CANCER RESISTANCE; CHEMICAL STRUCTURE; CHINESE MEDICINE; COMPUTER MODEL; COMPUTER PROGRAM; DRUG ACTIVITY; DRUG DESIGN; DRUG SYNTHESIS; EDITORIAL; HERBAL MEDICINE; HOST; MOLECULAR MODEL; MOLECULARLY TARGETED THERAPY; MULTIDRUG RESISTANCE; PREDICTION; PRIORITY JOURNAL; STATISTICS; TRADITIONAL MEDICINE; BIOLOGY; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG DEVELOPMENT; DRUG INDUSTRY; HUMAN; METHODOLOGY;

BIOLOGICAL PRODUCTS; COMPUTATIONAL BIOLOGY; DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG DISCOVERY; DRUG INDUSTRY; HUMANS;

EID: 78049508113     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161210791164045     Document Type: Editorial

References (16)

1. Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod 2007; 70: 461-477.
2. Henkel T, Brunne RM, Muller H, Reichel F. Statistical investigation into the structural complementarity of natural products and synthetic compounds. Angew Chem Int Ed 1999; 38: 643-647.
3. Ekins S, Mestres J, Testa B. In silico pharmacology for drug discovery: applications to targets and beyond. Brit J Pharmacol 2007; 152: 21-37.
4. Ekins S, Mestres J, Testa B. In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling. Brit J Pharmacol 2007; 152: 9-20.
5. Rollinger JM, Langer T, Stuppner H. Strategies for efficient lead structure discovery from natural products. Curr Med Chem 2006; 13: 1491-507.
6. Rollinger JM, Stuppner H, Langer T. Virtual Screening for the Discovery of Bioactive Natural Products. In: Petersen F, Amstutz R, Eds, Natural Compounds as Drugs. Basel, Switzerland: Birkhäuser Verlag 2008; vol. I: 212-249.
7. JM. Accessing target information by virtual parallel screening - The impact on natural product research. Phytochem Lett 2009; 2: 53-58.
8. Hiss JA, Hartenfeller M, Schneider G. Concepts and applications of "natural computing" techniques in de novo drug and peptide design. Curr Pharm Des 2010; 16(15): 1656-1665.
9. Schuster D, Wolber G. Identification of bioactive natural products by pharmacophore-based virtual screening. Curr Pharm Des 2010; 16(15): 1666-1681.
10. Blondeau S, Do QT, Scior T, Bernard P, Morin-Allory L. Reverse pharmacognosy: another way to harness the generosity of nature. Curr Pharm Des 2010; 16(15): 1682-1696.
11. Clark RL, Johnston BF, Mackay SP, Breslin CJ, Robertson MN, Sutcliffe OB, et al. The drug discovery portal: a computational platform for identifying drug leads from academia. Curr Pharm Des 2010; 16(15): 1697-1702.
12. Lagunin A, Filimonov D, Poroikov V. Multi-targeted natural products evaluation based on biological activity prediction with PASS. Curr Pharm Des 2010; 16(15): 1703-1717.
13. Pfisterer PH, Wolber G, Efferth T, Rollinger JM, Stuppner H. Natural products in structure-assisted design of molecular cancer therapeutics. Curr Pharm Des 2010; 16(15): 1718-1741.
14. Klepsch F, Jabeen I, Chiba P, Ecker GF. Pharmacoinformatic approaches to design natural product type ligands of ABC-transporters. Curr Pharm Des 2010; 16(15): 1742-52.
15. Sangma C, Chuakheaw D, Jonkon N, Gadavanij S. Computer techniques for drug development from Thai traditional medicine. Curr Pharm Des 2010; 16(15): 1753-1784.
16. Ehrman TM, Barlow DJ, Hylands PJ. Phytochemical informatics and virtual screening of herbs used in Chinese medicine. Curr Pharm Des 2010; 16(15): 1785-1798.